Results 131 to 140 of about 78,600 (311)

GENETIC DIAGNOSTICS OF HEMOPHILIA A

Zdravniški Vestnik, 2004
Background. Hemophilia A is a chromosome X-linked bleeding disorder due to mutations in the FVIII gene. There are 163 hemophilia A patients in Slovene registry for Hemophilia.
Maruša Debeljak, Majda Benedik Dolničar, Lana Strmecki   +2 more
doaj  

Comprehensive Management of Hemophilia [PDF]

, 1977
Caroline Rizza
openalex   +1 more source

Retrospective Evaluation of Cryoprecipitate Transfusion in Dogs to Prevent or Treat Hemorrhage: 21 Cases (2009–2023)

Journal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To report homologous cryoprecipitate transfusions in dogs with hemostatic disorders, hemorrhage, or risk of hemorrhage, and to report adverse reactions associated with these cryoprecipitate transfusions. Design Retrospective case series (July 2009 to July 2023). Setting University teaching hospital.
W. Y. Eunice Lam, Linda G. Martin, K. Jane Wardrop, Jillian M. Haines   +3 more
wiley   +1 more source

Expression and Linkage of Genes for X-linked Hemophilias A and B in the Dog [PDF]

, 1973
K. M. Brinkhous, Peter D. Davis, John B. Graham, W. Jean Dodds   +3 more
openalex   +1 more source

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. [PDF]

, 2019
Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis for the strongest of these ...
Anderson, Stephen K, Carrington, Mary, Chowdhury, Fatema Z, Deeks, Steven G, Ewy, Rodger, Gatanaga, Hiroyuki, Goedert, James J, Haas, David W, Hoots, W Keith, Kirk, Gregory D, Kulkarni, Smita, Kulkarni, Viraj, Le Gall, Sylvie, Lied, Alexandra, Lin, Zhansong, Margolick, Joseph, Martin, Maureen P, McLaren, Paul J, Michael, Nelson, Naranbhai, Vivek, Nguyen, Hoang, Oka, Shinichi, Rucevic, Marijana, Singh, Sukhvinder, Takiguchi, Masafumi, Thio, Chloe L, Viard, Mathias, Walker, Bruce, Walker-Sperling, Victoria, Yu, Xu G, Zou, Chengcheng   +30 more
core  

Accelerated Adeno Associated Virus Upstream Process Development From High‐Throughput Systems to Clinical Scale

Biotechnology and Bioengineering, Volume 122, Issue 11, Page 3051-3060, November 2025.
Accelerated, quality‐by‐design‐driven development and scale‐up of recombinant AAV production, from high‐throughput bench scale to commercial scale. ABSTRACT Adeno‐associated virus (AAV) is one of the most common delivery systems used in gene therapy.
Angela Andaluz, Brittany Monteverde, Kevin Vera, Brandon Tse, Ivan Gajic, Clifford Forelich, Seyed Pouria Motevalian   +6 more
wiley   +1 more source

The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista, Diego Martinelli, Marco Spada, Carlo Dionisi‐Vici   +3 more
wiley   +1 more source

Effectiveness of Octocog Alfa (BAY 81‐8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under‐Represented Subgroups

European Journal of Haematology, Volume 115, Issue 5, Page 484-492, November 2025.
ABSTRACT Objectives To evaluate the real‐world effectiveness of octocog alfa (BAY 81‐8973; Kovaltry) in people with haemophilia A (PwHA), including under‐represented subgroups. Methods We retrospectively analysed the American Thrombosis and Hemostasis Network (ATHN) dataset to identify the characteristics, treatment/clinical histories and annualised ...
Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht   +4 more
wiley   +1 more source

Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccines

Frontiers in Bioengineering and Biotechnology
Reverse vaccine formulations have shown their potential for the treatment of allergies and other autoimmune diseases by the design of antigens that modify dendritic cell function towards tolerogenic responses.
Eleonora Nardini, Eleonora Nardini, Brigitte-Carole Keumatio Doungstop, Brigitte-Carole Keumatio Doungstop, Tania Gerpe-Amor, Aram M. de Haas, Aram M. de Haas, Mike de Kok, Evert Peterse, Evert Peterse, Hakan Kalay, Rui-Jún E. Li, Fabrizio Chiodo, Fabrizio Chiodo, Fabrizio Chiodo, Alba Silipo, Jan Voorberg, Yvette van Kooyk, Yvette van Kooyk, Yvette van Kooyk   +19 more
doaj   +1 more source

VOLKMANNʼS ISCHEMIC CONTRACTURE IN HEMOPHILIA

, 1936
Rogers Lee Hill, Barney Brooks
openalex   +2 more sources